{
    "clinical_study": {
        "@rank": "126302", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Experimental", 
                "description": "Participants will receive oral bovine type I collagen (CI) daily for 15 months"
            }, 
            {
                "arm_group_label": "2", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Participants will receive placebo daily for 15 months."
            }
        ], 
        "brief_summary": {
            "textblock": "Diffuse systemic sclerosis (SSc), or scleroderma, is a connective tissue disease causing\n      damage to skin and other organs. The purpose of this study is to determine if taking oral\n      bovine type I collagen (CI) will improve the condition of SSc patients."
        }, 
        "brief_title": "Oral Type I Collagen for Relieving Scleroderma", 
        "condition": [
            "Scleroderma", 
            "Connective Tissue Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Connective Tissue Diseases", 
                "Scleroderma, Systemic", 
                "Scleroderma, Diffuse", 
                "Scleroderma, Localized"
            ]
        }, 
        "detailed_description": {
            "textblock": "SSc is a chronic connective tissue disease that is caused by excess collagen deposits that\n      damage the skin and other organs. This study will determine if a daily oral dose of bovine\n      CI will improve the condition of patients with SSc.\n\n      Patients will be randomly assigned to one of two groups. The first group will receive 500\n      mcg bovine CI daily for 15 months; the second group will receive placebo. Study visits will\n      be conducted at Months 4, 8, 12, and 15. Patients will undergo physical examination and\n      blood tests at each visit. Patients will also be evaluated for modified Rodnan skin score\n      (MRSS) and will be given health assessment questionnaires. A chest x-ray will be conducted\n      at study entry and pulmonary function tests will be conducted at study entry and Month 12."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of diffuse systemic scleroderma (by American College of\n             Rheumatology criteria 1980) of 10 years or less\n\n          -  Stable skin involvement by history or physical examination 6 months prior to study\n             entry\n\n          -  Stable modified Rodnan skin score (MRSS) for 1 month prior to study entry\n\n          -  Stable MRSS of 16 or more at screening and stable MRSS between screening and baseline\n             visit\n\n          -  Agree to use acceptable forms of contraception\n\n        Exclusion Criteria:\n\n          -  Participation in another clinical research study involving evaluation of another\n             investigational drug within 90 days prior to study entry\n\n          -  Concurrent serious medical condition which, in the opinion of the investigator, makes\n             the patient inappropriate for the study\n\n          -  Systemic sclerosis-like illnesses associated with environmental, ingested, or\n             injected agents, such as L-tryptophan, tainted rapeseed oil, vinyl chloride, or\n             bleomycin\n\n          -  Limited and localized (morphea) or linear SSc\n\n          -  Tenderness or swelling of the extremities (eosinophilic fasciitis)\n\n          -  Pregnancy\n\n          -  Use of certain medications\n\n          -  Allergy to beef or dairy products\n\n          -  Nonsteroidal anti-inflammatory drugs (NSAIDs) within 1 week before baseline visit.\n             Aspirin at 325 mg or less daily for stroke or heart attack prevention is allowed.\n\n          -  Use of herbal and some alternative therapies\n\n          -  Any organ transplant or stem cell transplant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "168", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 26, 2000", 
        "has_expanded_access": "Yes", 
        "id_info": {
            "nct_id": "NCT00005675", 
            "org_study_id": "N01 AR92242", 
            "secondary_id": "NIAMS-048"
        }, 
        "intervention": [
            {
                "arm_group_label": "1", 
                "description": "500 mcg of CI daily for 15 months", 
                "intervention_name": "Oral bovine type I collagen", 
                "intervention_type": "Drug", 
                "other_name": "CI"
            }, 
            {
                "arm_group_label": "2", 
                "description": "CI placebo daily for 15 months", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Systemic Scleroderma (SSc)", 
            "Bovine Type I Collagen (CI)", 
            "Multicenter"
        ], 
        "lastchanged_date": "May 24, 2010", 
        "link": {
            "description": "Division of The Connective Tissue Research Group of the University of Tennessee, Memphis", 
            "url": "http://www.uthsc.edu/ctr/"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "University of Alabama at Birmingham"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90024"
                    }, 
                    "name": "University of California Los Angeles"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Farmington", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06030-1310"
                    }, 
                    "name": "University of Connecticut"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21224"
                    }, 
                    "name": "Johns Hopkins University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02188"
                    }, 
                    "name": "Boston University School Of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Wayne State University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10003"
                    }, 
                    "name": "Beth Israel Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29425"
                    }, 
                    "name": "Medical University of South Carolina"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "38163"
                    }, 
                    "name": "University of Tennessee Health Science Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "The University of Texas Health Science Center at Houston"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98101"
                    }, 
                    "name": "Virginia Mason Research Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multicenter Phase II Trial of Oral Type I Bovine Collagen in Scleroderma", 
        "overall_official": {
            "affiliation": "University of Tennessee at Memphis", 
            "last_name": "Arnold E. Postlethwaite, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2005", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Disease condition, as measured by physical exam, modified Rodnan skin score (MRSS), health assessment questionnaires, chest x-ray, and pulmonary function tests", 
            "safety_issue": "No", 
            "time_frame": "Measured at Month 12"
        }, 
        "reference": [
            {
                "PMID": "11177772", 
                "citation": "Postlethwaite AE. Can we induce tolerance in rheumatoid arthritis? Curr Rheumatol Rep. 2001 Feb;3(1):64-9. Review."
            }, 
            {
                "PMID": "15334493", 
                "citation": "Carbone LD, McKown K, Pugazhenthi M, Barrow KD, Warrington K, Somes G, Postlethwaite AE. Dosage effects of orally administered bovine type I collagen on immune function in patients with systemic sclerosis. Arthritis Rheum. 2004 Aug;50(8):2713-5. No abstract available."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00005675"
        }, 
        "responsible_party": {
            "name_title": "Arnold E. Postlethwaite, MD", 
            "organization": "UTHSC"
        }, 
        "source": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Wayne State University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of California, Los Angeles", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "UTHSC", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "MUSC", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Beth Israel Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Alabama at Birmingham", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Johns Hopkins University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Georgetown University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Baltimore VA Medical Center", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "Northwestern University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 2000", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2008"
    }, 
    "geocoordinates": {
        "Beth Israel Medical Center": "40.714 -74.006", 
        "Boston University School Of Medicine": "42.358 -71.06", 
        "Georgetown University Medical Center": "38.895 -77.036", 
        "Johns Hopkins University": "39.29 -76.612", 
        "Medical University of South Carolina": "32.777 -79.931", 
        "The University of Texas Health Science Center at Houston": "29.76 -95.369", 
        "University of Alabama at Birmingham": "33.521 -86.802", 
        "University of California Los Angeles": "34.052 -118.244", 
        "University of Connecticut": "41.728 -72.84", 
        "University of Tennessee Health Science Center": "35.15 -90.049", 
        "Virginia Mason Research Center": "47.606 -122.332", 
        "Wayne State University": "42.331 -83.046"
    }
}